The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx ...
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...
The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...
MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback